Adage Capital Partners’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-400,000
Closed -$15.3M 890
2023
Q3
$15.3M Buy
+400,000
New +$16.4M 0.03% 470
2023
Q2
Sell
-614,000
Closed -$23.4M 893
2023
Q1
$23.4M Buy
614,000
+287,500
+88% +$13.5M 0.05% 376
2022
Q4
$18.6M Buy
+326,500
New +$16.7M 0.04% 451
2020
Q4
Sell
-800,000
Closed -$21M 849
2020
Q3
$21M Sell
800,000
-200,000
-20% -$5.57M 0.05% 364
2020
Q2
$26.8M Buy
1,000,000
+300,000
+43% +$6.77M 0.07% 311
2020
Q1
$12.6M Sell
700,000
-425,000
-38% -$8.07M 0.04% 417
2019
Q4
$19.9M Buy
1,125,000
+375,000
+50% +$6.49M 0.05% 387
2019
Q3
$11.6M Buy
750,000
+300,000
+67% +$4.94M 0.03% 494
2019
Q2
$7.73M Buy
450,000
+300,000
+200% +$4.84M 0.02% 559
2019
Q1
$2.42M Buy
+150,000
New +$2.43M 0.01% 645
2018
Q1
Sell
-250,000
Closed -$5.07M 741
2017
Q4
$5.07M Hold
250,000
0.01% 624
2017
Q3
$4.34M Sell
250,000
-75,000
-23% -$1.02M 0.01% 635
2017
Q2
$4.17M Buy
325,000
+225,000
+225% +$3.01M 0.01% 643
2017
Q1
$1.3M Buy
+100,000
New +$1.26M ﹤0.01% 673
2014
Q2
Sell
-187,584
Closed -$2.38M 718
2014
Q1
$2.38M Buy
+187,584
New +$2.78M 0.01% 638

Other funds holding HALO

Adage Capital Partners's HALO Position: Q4 2023 in Review

Adage Capital Partners sold out of Halozyme (HALO) in Q4 2023, closing a stake of 400,000 shares — an estimated $15.3M sold.

Adage Capital Partners first reported a position in HALO in Q1 2014 and held it in 15 quarters. The position peaked at $26.8M in Q2 2020. 410 funds tracked by Wall St. Rank hold HALO as of Q4 2023.

  • Adage Capital Partners reported no remaining Halozyme position as of Q4 2023 after selling out during the quarter.
  • Adage Capital Partners sold 400,000 Halozyme shares in Q4 2023, an estimated $15.3M.
  • Adage Capital Partners first reported a position in Halozyme in Q1 2014 and held it in 15 quarters.
  • Adage Capital Partners's Halozyme position peaked at $26.8M in Q2 2020.
  • 410 funds tracked by Wall St. Rank held Halozyme as of Q4 2023.

Based on Adage Capital Partners's 13F filing for Q4 2023, filed 14 Feb 2024.